Dr Mustafa Khasraw

Research Fellow
NHMRC Clinical Trials Centre, Sydney Medical School

Telephone +61468971487

Map

Biographical details

Dr. Khasraw is a research fellow at the NHMRC Clinical Trials Centre, University of Sydney.

He is also a senior lecturer at Deakin University, the clinical lead in research at the Andrew Love Cancer Centre in Geelong and a consultant medical oncologist at The Geelong and Royal Melbourne Hospitals. He trained in medical oncology in Sydney and later at Memorial Sloan-Kettering Cancer Centre in New York, USA.

Research interests

Dr Khasraw is the research fellow at The Cooperative Trials Group for Neuro-Oncology (COGNO) and he is also involved in numerous collaborative research projects across different tumour streams.

Selected publications

Download citations: PDF RTF Endnote

Book Chapters

  • Khasraw, M., Noy, A., Gilbert, M., Omuro, A. (2012). Neurological Complications of Non-Hodgkin Lymphoma. In Tracy Batchelor, Lisa M DeAngelis (Eds.), Lymphoma and Leukemia of the Nervous System, (pp. 267-286). New York: Springer Science + Business Media.
  • Khasraw, M., Khakoo, Y. (2012). Paraneoplastic Syndromes Affecting the Nervous System. In Kenneth F. Swaiman, Stephen Ashwal, Donna M Ferriero, Nina F Schor (Eds.), Swaiman's Pediatric Neurology: Principles and Practice, 5th Ed, (pp. 1388-1394). Canada: Elsevier Inc.

Journals

  • Khasraw, M., Simeonovic, M., Grommes, C. (2014). Bevacizumab for the treatment of high-grade glioma. Expert Opinion on Biological Therapy, 12(8), 1101-1111. [More Information]
  • Hao-Wen, S., Morris, P., Patil, S., Khasraw, M. (2014). Brain metastases in breast cancer. Expert Review of Anticancer Therapy: an essential contribution to decision making in cancer care, 14(2), 173-183. [More Information]
  • Gupta, S., Tran, T., Luo, W., Phung, D., Kennedy, R., Broad, A., Campbell, D., Kipp, D., Singh, M., Khasraw, M., et al (2014). Machine-learning prediction of cancer survival: a retrospective study using electronic administrative records and a cancer registry. BMJ Open, 4(3), e004007. [More Information]
  • Harvey, S., Khasraw, M. (2013). Alternative targeted therapy for early HER2 positive breast cancer. Unknown, 2(1), 42-45.
  • Davis, J., Ahlberg, F., Berk, M., Ashley, D., Khasraw, M. (2013). Emerging pharmacotherapy for cancer patients with cognitive dysfunction. BMC Neurology, 13, 1-9. [More Information]
  • Lomax, A., Yap, S., Khasraw, M. (2013). Intraaortic metastases or intraarterial thrombus. International Journal of Case Reports and Images, 4(7), 368-371.
  • Khasraw, M., Yap, S., Ananda, S. (2013). Neuroendocrine neoplasms of the GI tract: the role of cytotoxic chemotherapy. Expert Review of Anticancer Therapy: an essential contribution to decision making in cancer care, 13(4), 451-459. [More Information]
  • Omuro, A., Chan, T., Abrey, L., Khasraw, M., Reiner, A., Kaley, T., DeAngelis, L., Lassman, A., Nolan, C., Gavrilovic, I., et al (2013). Phase II trial of continuous low-dose temozolomide for patients with recurrent malignant glioma. Neuro-Oncology, 15(2), 242-250. [More Information]
  • Domchek, S., Jhaveri, K., Patil, S., Stopfer, J., Hudis, C., Powers, J., Stadler, Z., Goldstein, L., Kauff, N., Khasraw, M., et al (2013). Risk of metachronous breast cancer after BRCA mutation-associated ovarian cancer. Cancer, 119(7), 1344-1348. [More Information]
  • Mustafa, B., Samaan, M., Langmead, L., Khasraw, M. (2013). Small bowel video capsule endoscopy: an overview. Expert Review of Gastroenterology and Hepatology, 7(4), 323-329. [More Information]
  • Sheet, S., Sheikha, A., Saeed, A., Ameen, H., Mohammed, S., Khasraw, M. (2012). Colorectal cancer: is the incidence rising in young Iraqi patients? Asia-Pacific Journal of Clinical Oncology, 8(4), 380-381. [More Information]
  • Khasraw, M., Bell, R., Dang, C. (2012). Epirubicin: Is it like doxorubicin in breast cancer? A clinical review. The Breast, 21(2), 142-149. [More Information]
  • Khasraw, M., Harvey, S., Bell, R. (2012). Hormonal Resistance in Breast Cancer: Evolving Treatment Strategies. Current Breast Cancer Reports, 4(1), 66-74. [More Information]
  • Khasraw, M., Holodny, A., Goldlust, S., DeAngelis, L. (2012). Intracranial hemorrhage in patients with cancer treated with bevacizumab: the Memorial Sloan-Kettering experience. Annals of Oncology, 23(2), 458-463. [More Information]
  • Khasraw, M., Bell, R. (2012). Primary systemic therapy in HER2-amplified breast cancer: a clinical review. Expert Review of Anticancer Therapy, 12(8), 1005-1013. [More Information]
  • Khasraw, M., Ashley, D., Wheeler, G., Berk, M. (2012). Using lithium as a neuroprotective agent in patients with cancer. BMC Medicine, 10, 1-7. [More Information]
  • Khasraw, M., Robson, M. (2011). Poly(ADP-ribose) polymerase inhibitors in breast cancer and other tumors: advances and challenges. Clinical Investigation, 1(11), 1545-1554. [More Information]
  • Khasraw, M., Brogi, E., Seidman, A. (2011). The Need to Examine Metastatic Tissue at the Time of Progression of Breast Cancer: Is Re-biopsy a Necessity or a Luxury? Current Oncology Reports, 13(1), 17-25. [More Information]
  • Khasraw, M., Lassman, A. (2010). Advances in the Treatment of Malignant Gliomas. Current Oncology Reports, 12(1), 26-33. [More Information]
  • Khasraw, M., Lassman, A., Wheeler, H., Pavlakis, N. (2010). Anti-angiogenic therapy for high grade glioma (Protocol). Cochrane Database of Systematic Reviews, 2, 1-9.
  • Murphy, C., Khasraw, M., Seidman, A. (2010). Holding back the sea: the role for maintenance chemotherapy in metastatic breast cancer. Breast Cancer Research and Treatment, 122(1), 177-179. [More Information]
  • Khasraw, M., Pavlakis, N., McCowatt, S., Underhill, C., Begbie, S., De Souza, P., Boyce, A., Parnis, F., Lim, V., Harvie, R., et al (2010). Multicentre phase I/II study of PI-88, a heparanase inhibitor in combination with docetaxel in patients with metastatic castrate-resistant prostate cancer. Annals of Oncology, 21(6), 1302-1307. [More Information]
  • Khasraw, M., Posner, J. (2010). Neurological complications of systemic cancer. Lancet Neurology, 9(12), 1214-1227.
  • Khasraw, M., Townsend, A., Price, T., Hart, J., Bell, D., Pavlakis, N. (2010). Objective radiological disease control with Sandostatin monotherapy in metastatic neuroendocrine tumours. Internal Medicine Journal, 40(6), 453-458. [More Information]
  • Khasraw, M., Faraj, H., Sheikha, A. (2010). Thrombocytopenia in Solid Tumors. European Journal of Clinical & Medical Oncology, 2(2), 1-4.
  • Khasraw, M., Atkinson, C., Van der Saag, D., Pavlakis, N., Guminski, A. (2009). Cardiac toxicity from sunitinib: Do we need to be more vigilant? Asia-Pacific Journal of Clinical Oncology, 5(4), 217-218. [More Information]
  • Khasraw, M., Baron-Hay, S. (2009). Immune thrombocytopenic purpura (ITP) and breast cancer. Does adjuvant therapy for breast cancer improve platelet counts in ITP? Annals of Oncology, 20(7), 1282-1283. [More Information]
  • Khasraw, M., Bell, D., Wheeler, H. (2009). Long-term use of temozolomide: Could you use temozolomide safely for life in gliomas? Journal of Clinical Neuroscience, 16(6), 854-855. [More Information]
  • Khasraw, M., Gill, A., Harrington, T., Pavlakis, N., Modlin, I. (2009). Management of Advanced Neuroendocrine Tumors With Hepatic Metastasis. Journal of Clinical Gastroenterology, 43(9), 838-47. [More Information]
  • Khasraw, M., Lassman, A. (2009). Neuro-oncology: late neurocognitive decline after radiotherapy for low-grade glioma. Nature Reviews Neurology, 5(12), 646-647. [More Information]
  • Khasraw, M., Marx, G. (2008). Chemotherapy in the Elderly. Cancer Forum, 32(1), 1-4.

2014

  • Khasraw, M., Simeonovic, M., Grommes, C. (2014). Bevacizumab for the treatment of high-grade glioma. Expert Opinion on Biological Therapy, 12(8), 1101-1111. [More Information]
  • Hao-Wen, S., Morris, P., Patil, S., Khasraw, M. (2014). Brain metastases in breast cancer. Expert Review of Anticancer Therapy: an essential contribution to decision making in cancer care, 14(2), 173-183. [More Information]
  • Gupta, S., Tran, T., Luo, W., Phung, D., Kennedy, R., Broad, A., Campbell, D., Kipp, D., Singh, M., Khasraw, M., et al (2014). Machine-learning prediction of cancer survival: a retrospective study using electronic administrative records and a cancer registry. BMJ Open, 4(3), e004007. [More Information]

2013

  • Harvey, S., Khasraw, M. (2013). Alternative targeted therapy for early HER2 positive breast cancer. Unknown, 2(1), 42-45.
  • Davis, J., Ahlberg, F., Berk, M., Ashley, D., Khasraw, M. (2013). Emerging pharmacotherapy for cancer patients with cognitive dysfunction. BMC Neurology, 13, 1-9. [More Information]
  • Lomax, A., Yap, S., Khasraw, M. (2013). Intraaortic metastases or intraarterial thrombus. International Journal of Case Reports and Images, 4(7), 368-371.
  • Khasraw, M., Yap, S., Ananda, S. (2013). Neuroendocrine neoplasms of the GI tract: the role of cytotoxic chemotherapy. Expert Review of Anticancer Therapy: an essential contribution to decision making in cancer care, 13(4), 451-459. [More Information]
  • Omuro, A., Chan, T., Abrey, L., Khasraw, M., Reiner, A., Kaley, T., DeAngelis, L., Lassman, A., Nolan, C., Gavrilovic, I., et al (2013). Phase II trial of continuous low-dose temozolomide for patients with recurrent malignant glioma. Neuro-Oncology, 15(2), 242-250. [More Information]
  • Domchek, S., Jhaveri, K., Patil, S., Stopfer, J., Hudis, C., Powers, J., Stadler, Z., Goldstein, L., Kauff, N., Khasraw, M., et al (2013). Risk of metachronous breast cancer after BRCA mutation-associated ovarian cancer. Cancer, 119(7), 1344-1348. [More Information]
  • Mustafa, B., Samaan, M., Langmead, L., Khasraw, M. (2013). Small bowel video capsule endoscopy: an overview. Expert Review of Gastroenterology and Hepatology, 7(4), 323-329. [More Information]

2012

  • Sheet, S., Sheikha, A., Saeed, A., Ameen, H., Mohammed, S., Khasraw, M. (2012). Colorectal cancer: is the incidence rising in young Iraqi patients? Asia-Pacific Journal of Clinical Oncology, 8(4), 380-381. [More Information]
  • Khasraw, M., Bell, R., Dang, C. (2012). Epirubicin: Is it like doxorubicin in breast cancer? A clinical review. The Breast, 21(2), 142-149. [More Information]
  • Khasraw, M., Harvey, S., Bell, R. (2012). Hormonal Resistance in Breast Cancer: Evolving Treatment Strategies. Current Breast Cancer Reports, 4(1), 66-74. [More Information]
  • Khasraw, M., Holodny, A., Goldlust, S., DeAngelis, L. (2012). Intracranial hemorrhage in patients with cancer treated with bevacizumab: the Memorial Sloan-Kettering experience. Annals of Oncology, 23(2), 458-463. [More Information]
  • Khasraw, M., Noy, A., Gilbert, M., Omuro, A. (2012). Neurological Complications of Non-Hodgkin Lymphoma. In Tracy Batchelor, Lisa M DeAngelis (Eds.), Lymphoma and Leukemia of the Nervous System, (pp. 267-286). New York: Springer Science + Business Media.
  • Khasraw, M., Khakoo, Y. (2012). Paraneoplastic Syndromes Affecting the Nervous System. In Kenneth F. Swaiman, Stephen Ashwal, Donna M Ferriero, Nina F Schor (Eds.), Swaiman's Pediatric Neurology: Principles and Practice, 5th Ed, (pp. 1388-1394). Canada: Elsevier Inc.
  • Khasraw, M., Bell, R. (2012). Primary systemic therapy in HER2-amplified breast cancer: a clinical review. Expert Review of Anticancer Therapy, 12(8), 1005-1013. [More Information]
  • Khasraw, M., Ashley, D., Wheeler, G., Berk, M. (2012). Using lithium as a neuroprotective agent in patients with cancer. BMC Medicine, 10, 1-7. [More Information]

2011

  • Khasraw, M., Robson, M. (2011). Poly(ADP-ribose) polymerase inhibitors in breast cancer and other tumors: advances and challenges. Clinical Investigation, 1(11), 1545-1554. [More Information]
  • Khasraw, M., Brogi, E., Seidman, A. (2011). The Need to Examine Metastatic Tissue at the Time of Progression of Breast Cancer: Is Re-biopsy a Necessity or a Luxury? Current Oncology Reports, 13(1), 17-25. [More Information]

2010

  • Khasraw, M., Lassman, A. (2010). Advances in the Treatment of Malignant Gliomas. Current Oncology Reports, 12(1), 26-33. [More Information]
  • Khasraw, M., Lassman, A., Wheeler, H., Pavlakis, N. (2010). Anti-angiogenic therapy for high grade glioma (Protocol). Cochrane Database of Systematic Reviews, 2, 1-9.
  • Murphy, C., Khasraw, M., Seidman, A. (2010). Holding back the sea: the role for maintenance chemotherapy in metastatic breast cancer. Breast Cancer Research and Treatment, 122(1), 177-179. [More Information]
  • Khasraw, M., Pavlakis, N., McCowatt, S., Underhill, C., Begbie, S., De Souza, P., Boyce, A., Parnis, F., Lim, V., Harvie, R., et al (2010). Multicentre phase I/II study of PI-88, a heparanase inhibitor in combination with docetaxel in patients with metastatic castrate-resistant prostate cancer. Annals of Oncology, 21(6), 1302-1307. [More Information]
  • Khasraw, M., Posner, J. (2010). Neurological complications of systemic cancer. Lancet Neurology, 9(12), 1214-1227.
  • Khasraw, M., Townsend, A., Price, T., Hart, J., Bell, D., Pavlakis, N. (2010). Objective radiological disease control with Sandostatin monotherapy in metastatic neuroendocrine tumours. Internal Medicine Journal, 40(6), 453-458. [More Information]
  • Khasraw, M., Faraj, H., Sheikha, A. (2010). Thrombocytopenia in Solid Tumors. European Journal of Clinical & Medical Oncology, 2(2), 1-4.

2009

  • Khasraw, M., Atkinson, C., Van der Saag, D., Pavlakis, N., Guminski, A. (2009). Cardiac toxicity from sunitinib: Do we need to be more vigilant? Asia-Pacific Journal of Clinical Oncology, 5(4), 217-218. [More Information]
  • Khasraw, M., Baron-Hay, S. (2009). Immune thrombocytopenic purpura (ITP) and breast cancer. Does adjuvant therapy for breast cancer improve platelet counts in ITP? Annals of Oncology, 20(7), 1282-1283. [More Information]
  • Khasraw, M., Bell, D., Wheeler, H. (2009). Long-term use of temozolomide: Could you use temozolomide safely for life in gliomas? Journal of Clinical Neuroscience, 16(6), 854-855. [More Information]
  • Khasraw, M., Gill, A., Harrington, T., Pavlakis, N., Modlin, I. (2009). Management of Advanced Neuroendocrine Tumors With Hepatic Metastasis. Journal of Clinical Gastroenterology, 43(9), 838-47. [More Information]
  • Khasraw, M., Lassman, A. (2009). Neuro-oncology: late neurocognitive decline after radiotherapy for low-grade glioma. Nature Reviews Neurology, 5(12), 646-647. [More Information]

2008

  • Khasraw, M., Marx, G. (2008). Chemotherapy in the Elderly. Cancer Forum, 32(1), 1-4.

To update your profile click here. For support on your academic profile contact .